Novel KIF18A inhibitor, ATX-295, shows enriched activity in ovarian and TNBC preclinical models with whole genome doubling First-in-class DHX9 inhibitor,
LAS VEGAS, Oct. 22, 2025 /PRNewswire/ -- In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology
LAS VEGAS, Oct. 22, 2025 /PRNewswire/ -- In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology
LAS VEGAS, Oct. 22, 2025 /PRNewswire/ -- In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology
Technologies developed through foreign collaborations will now qualify as indigenous if they are adapted or customised in India and demonstrate
Technologies developed through foreign collaborations will now qualify as indigenous if they are adapted or customised in India and demonstrate
Technologies developed through foreign collaborations will now qualify as indigenous if they are adapted or customised in India and demonstrate
Investors are also closely watching the progress of US-China trade talks as officials from both countries are set to meet
Investors are also closely watching the progress of US-China trade talks as officials from both countries are set to meet
Investors are also closely watching the progress of US-China trade talks as officials from both countries are set to meet